Trump-touted hydroxychloroquine shows no benefit in COVID-19 prevention: study
(Reuters) - A malaria drug taken by U.S. President Donald Trump to prevent COVID-19 did not show any benefit versus placebo in reducing coronavirus infection among healthcare workers, according to clinical trial results published on Wednesday.
Comments
Post a Comment